Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Red Arrow Therapeutics Inc. closes $4.5M Seed Extension round | ||
By: PR Newswire Association LLC. - 23 Apr 2024 | Back to overview list |
|
BOSTON, April 23, 2024 /PRNewswire/ -- Red Arrow Therapeutics Inc. closed a $4.5M Seed Extension round, raising from four, top-tier institutional investors in Japan. Participants of this round are:
This boosts the accumulative funding raised by Red Arrow Therapeutics to nearly $5.5M, along with previous funding from The University of Tokyo Edge Capital Partners Co., Ltd., University of California, Berkeley's accelerator SkyDeck , and other non-dilutive funding. Emerging from the University of Tokyo's Cabral Lab in 2021, Red Arrow Therapeutics Inc. develops pH-sensing nanomedicine drug delivery technologies for multiple therapeutic areas such as oncology. Headquartered in Boston, Massachusetts, the company is committed to delivering cutting-edge technology for patients in need worldwide. The Seed extension round will allow Red Arrow Therapeutics to obtain key preclinical data on safety and efficacy of their lead compound, IL-12-loaded nanopolymeric micelles. The funding will also enable manufacturing initiation in collaboration with external partners. Red Arrow Therapeutics, Inc. Founders: Takuya Miyazaki, Ph.D. , Horacio Cabral, Ph.D., and Rika Tajima, MPH Founded Date: August 19, 2021 Address:
Website: https://redarrowtx.com/ Contact: https://redarrowtx.com/contact/ Rika Tajima
View original content:https://www.prnewswire.com/news-releases/red-arrow-therapeutics-inc-closes-4-5m-seed-extension-round-302121980.html SOURCE Red Arrow Therapeutics Inc. |
||
|
||
Copyright 2024 PR Newswire Association LLC. | Back to overview list |